APO Research, Inc.

APO RESEARCH · REPORT

AI-powered Coronary Artery Calcium (CAC) Analysis Software

Selected research

Market Outlook & Growth Opportunities

Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Outlook and Growth Opportunities 2026

Market perspective

The global AI-powered Coronary Artery Calcium (CAC) Analysis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-powered Coronary Artery Calcium (CAC) Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-powered Coronary Artery Calcium (CAC) Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-powered Coronary Artery Calcium (CAC) Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-powered Coronary Artery Calcium (CAC) Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-powered Coronary Artery Calcium (CAC) Analysis Software market include Aidoc, Cleerly, Nanox.AI, HeartFlow, Siemens Healthineers, Canon Medical Systems, RADLogics, GE HealthCare and Philips Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-powered Coronary Artery Calcium (CAC) Analysis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-powered Coronary Artery Calcium (CAC) Analysis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market.

AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Company

Aidoc

Cleerly

Nanox.AI

HeartFlow

Siemens Healthineers

Canon Medical Systems

RADLogics

GE HealthCare

Philips Healthcare

Infervision

Deepwise

RSIP Vision

AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Type

Dedicated Calcification Scoring Software

Enhanced CT Plaque Analysis Software

AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Application

Clinical Diagnosis Treatment

Health Management

Scientific Research

Other

AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-powered Coronary Artery Calcium (CAC) Analysis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-powered Coronary Artery Calcium (CAC) Analysis Software key companies, revenue, market share, and recent developments.

3. To split the AI-powered Coronary Artery Calcium (CAC) Analysis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-powered Coronary Artery Calcium (CAC) Analysis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-powered Coronary Artery Calcium (CAC) Analysis Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI-powered Coronary Artery Calcium (CAC) Analysis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-powered Coronary Artery Calcium (CAC) Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-powered Coronary Artery Calcium (CAC) Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-powered Coronary Artery Calcium (CAC) Analysis Software industry.

Chapter 3: Detailed analysis of AI-powered Coronary Artery Calcium (CAC) Analysis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-powered Coronary Artery Calcium (CAC) Analysis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-powered Coronary Artery Calcium (CAC) Analysis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Trends Table 2. AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Drivers Table 3. AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Opportunities and Challenges Table 4. AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Restraints Table 5. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue Share by Company (2021-2026) Table 7. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Key Company Manufacturing Base & Headquarters Table 9. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company, Product Type & Application Table 10. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dedicated Calcification Scoring Software Table 15. Significant Companies of Enhanced CT Plaque Analysis Software Table 16. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type (2021-2026) Table 20. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Diagnosis Treatment Table 22. Significant Companies of Health Management Table 23. Significant Companies of Scientific Research Table 24. Significant Companies of Other Table 25. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application (2021-2026) Table 29. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application (2027-2032) Table 30. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Region (2021-2026) Table 33. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Region (2027-2032) Table 35. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Market Share by Country (2021-2026) Table 38. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Market Share by Country (2027-2032) Table 40. Aidoc Company Information Table 41. Aidoc Business Overview Table 42. Aidoc AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Aidoc AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 44. Aidoc Recent Development Table 45. Cleerly Company Information Table 46. Cleerly Business Overview Table 47. Cleerly AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Cleerly AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 49. Cleerly Recent Development Table 50. Nanox.AI Company Information Table 51. Nanox.AI Business Overview Table 52. Nanox.AI AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Nanox.AI AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 54. Nanox.AI Recent Development Table 55. HeartFlow Company Information Table 56. HeartFlow Business Overview Table 57. HeartFlow AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. HeartFlow AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 59. HeartFlow Recent Development Table 60. Siemens Healthineers Company Information Table 61. Siemens Healthineers Business Overview Table 62. Siemens Healthineers AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Siemens Healthineers AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 64. Siemens Healthineers Recent Development Table 65. Canon Medical Systems Company Information Table 66. Canon Medical Systems Business Overview Table 67. Canon Medical Systems AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Canon Medical Systems AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 69. Canon Medical Systems Recent Development Table 70. RADLogics Company Information Table 71. RADLogics Business Overview Table 72. RADLogics AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. RADLogics AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 74. RADLogics Recent Development Table 75. GE HealthCare Company Information Table 76. GE HealthCare Business Overview Table 77. GE HealthCare AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GE HealthCare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 79. GE HealthCare Recent Development Table 80. Philips Healthcare Company Information Table 81. Philips Healthcare Business Overview Table 82. Philips Healthcare AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Philips Healthcare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 84. Philips Healthcare Recent Development Table 85. Infervision Company Information Table 86. Infervision Business Overview Table 87. Infervision AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Infervision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 89. Infervision Recent Development Table 90. Deepwise Company Information Table 91. Deepwise Business Overview Table 92. Deepwise AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Deepwise AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 94. Deepwise Recent Development Table 95. RSIP Vision Company Information Table 96. RSIP Vision Business Overview Table 97. RSIP Vision AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. RSIP Vision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio Table 99. RSIP Vision Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Image Figure 2. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dedicated Calcification Scoring Software Image Figure 8. Enhanced CT Plaque Analysis Software Image Figure 9. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type (2021-2032) Figure 12. Clinical Diagnosis Treatment Image Figure 13. Health Management Image Figure 14. Scientific Research Image Figure 15. Other Image Figure 16. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application (2021-2032) Figure 19. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Dedicated Calcification Scoring Software
  • Enhanced CT Plaque Analysis Software
Applications
  • Clinical Diagnosis Treatment
  • Health Management
  • Scientific Research
  • Other
Companies covered
  • Aidoc
  • Cleerly
  • Nanox.AI
  • HeartFlow
  • Siemens Healthineers
  • Canon Medical Systems
  • RADLogics
  • GE HealthCare
  • Philips Healthcare
  • Infervision
  • Deepwise
  • RSIP Vision

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Dynamics
  1. 2.1 AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Trends
  2. 2.2 AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Drivers
  3. 2.3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Opportunities and Challenges
  4. 2.4 AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Restraints
3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market by Company
  1. 3.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Revenue Ranking in 2025
  2. 3.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue by Company (2021-2026)
  3. 3.3 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Ranking (2024-2026)
  4. 3.4 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Product Type and Application
  6. 3.6 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-powered Coronary Artery Calcium (CAC) Analysis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market by Type
  1. 4.1 AI-powered Coronary Artery Calcium (CAC) Analysis Software Type Introduction
  2. 4.1.1 Dedicated Calcification Scoring Software
  3. 4.1.2 Enhanced CT Plaque Analysis Software
  4. 4.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type
  5. 4.2.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type (2021-2032)
5 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market by Application
  1. 5.1 AI-powered Coronary Artery Calcium (CAC) Analysis Software Application Introduction
  2. 5.1.1 Clinical Diagnosis Treatment
  3. 5.1.2 Health Management
  4. 5.1.3 Scientific Research
  5. 5.1.4 Other
  6. 5.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application
  7. 5.2.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application (2021-2032)
6 AI-powered Coronary Artery Calcium (CAC) Analysis Software Regional Value Analysis
  1. 6.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032)
  7. 6.3.2 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032)
  16. 6.6.2 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Country, 2025 VS 2032
7 AI-powered Coronary Artery Calcium (CAC) Analysis Software Country-level Value Analysis
  1. 7.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-powered Coronary Artery Calcium (CAC) Analysis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aidoc
  2. 8.1.1 Aidoc Company Information
  3. 8.1.2 Aidoc Business Overview
  4. 8.1.3 Aidoc AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aidoc AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  6. 8.1.5 Aidoc Recent Developments
  7. 8.2 Cleerly
  8. 8.2.1 Cleerly Company Information
  9. 8.2.2 Cleerly Business Overview
  10. 8.2.3 Cleerly AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cleerly AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  12. 8.2.5 Cleerly Recent Developments
  13. 8.3 Nanox.AI
  14. 8.3.1 Nanox.AI Company Information
  15. 8.3.2 Nanox.AI Business Overview
  16. 8.3.3 Nanox.AI AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanox.AI AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  18. 8.3.5 Nanox.AI Recent Developments
  19. 8.4 HeartFlow
  20. 8.4.1 HeartFlow Company Information
  21. 8.4.2 HeartFlow Business Overview
  22. 8.4.3 HeartFlow AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HeartFlow AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  24. 8.4.5 HeartFlow Recent Developments
  25. 8.5 Siemens Healthineers
  26. 8.5.1 Siemens Healthineers Company Information
  27. 8.5.2 Siemens Healthineers Business Overview
  28. 8.5.3 Siemens Healthineers AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  30. 8.5.5 Siemens Healthineers Recent Developments
  31. 8.6 Canon Medical Systems
  32. 8.6.1 Canon Medical Systems Company Information
  33. 8.6.2 Canon Medical Systems Business Overview
  34. 8.6.3 Canon Medical Systems AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Canon Medical Systems AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  36. 8.6.5 Canon Medical Systems Recent Developments
  37. 8.7 RADLogics
  38. 8.7.1 RADLogics Company Information
  39. 8.7.2 RADLogics Business Overview
  40. 8.7.3 RADLogics AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RADLogics AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  42. 8.7.5 RADLogics Recent Developments
  43. 8.8 GE HealthCare
  44. 8.8.1 GE HealthCare Company Information
  45. 8.8.2 GE HealthCare Business Overview
  46. 8.8.3 GE HealthCare AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GE HealthCare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  48. 8.8.5 GE HealthCare Recent Developments
  49. 8.9 Philips Healthcare
  50. 8.9.1 Philips Healthcare Company Information
  51. 8.9.2 Philips Healthcare Business Overview
  52. 8.9.3 Philips Healthcare AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Philips Healthcare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  54. 8.9.5 Philips Healthcare Recent Developments
  55. 8.10 Infervision
  56. 8.10.1 Infervision Company Information
  57. 8.10.2 Infervision Business Overview
  58. 8.10.3 Infervision AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Infervision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  60. 8.10.5 Infervision Recent Developments
  61. 8.11 Deepwise
  62. 8.11.1 Deepwise Company Information
  63. 8.11.2 Deepwise Business Overview
  64. 8.11.3 Deepwise AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Deepwise AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  66. 8.11.5 Deepwise Recent Developments
  67. 8.12 RSIP Vision
  68. 8.12.1 RSIP Vision Company Information
  69. 8.12.2 RSIP Vision Business Overview
  70. 8.12.3 RSIP Vision AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 RSIP Vision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
  72. 8.12.5 RSIP Vision Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.